RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253591

FDA DEVICE FACTS

Phantom® Hindfoot TTC/TC Nail System

Paragon 28, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 5, 2026PRODUCT CODEHSB

Indications for use

The Phantom® Hindfoot TTC/TC Nail System is indicated for tibiotalocalcaneal arthrodesis (fusion) and to provide stabilization of the hindfoot and ankle including the transverse tarsal joints coupling the mid-foot to the hindfoot. Examples of specific indications include:

• Post-traumatic or degenerative arthritis

• Previously infected arthrosis

• Revision of failed ankle arthrodesis

• Revision of failed total ankle arthroplasty

• Talar deficiency conditions such as avascular necrosis of the talus (requiring tibiocalcaneal arthrodesis)

• Neuromuscular deformity or other neuromuscular disease with severe deformity or instability of the ankle

• Rheumatoid arthritis

• Osteoarthritis

• Nonunions or pseudarthrosis of hindfoot and distal tibia

• Trauma (severe or malunited tibial pilon fracture)

• Charcot foot (neuroarthropathy)

• Severe end-stage degenerative arthritis

• Instability and skeletal defects after tumor resection

• Pantalar arthrodesis

• Severe foot/ankle deformity Prescription Use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026